COH Share Price

Open 138.25 Change Price %
High 139.59 1 Day 0.33 0.24
Low 137.37 1 Week 0.60 0.43
Close 138.90 1 Month 8.56 6.57
Volume 99874 1 Year 33.40 31.66
52 Week High 144.12
52 Week Low 103.70
COH Important Levels
Resistance 2 140.96
Resistance 1 140.11
Pivot 138.62
Support 1 137.69
Support 2 136.84
ASX Australia Most Active Stocks
AGO 0.02 0.00%
AGO 0.02 0.00%
AGO 0.02 0.00%
DUE 3.01 9.45%
DUE 3.01 9.45%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
TLS 4.23 -0.47%
TLS 4.23 -0.47%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
SRI 0.02 100.00%
SRI 0.02 100.00%
SRI 0.02 100.00%
SRI 0.02 100.00%
SRI 0.02 100.00%
BNV 0.03 50.00%
PMQ 0.03 50.00%
IRM 0.03 50.00%
IRM 0.03 50.00%
More..
ASX Australia Top Losers Stocks
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
GBZ 0.01 -50.00%
GDY 0.01 -50.00%
AVD 0.02 -33.33%
AVD 0.02 -33.33%
AVD 0.02 -33.33%
More..

Cochlear Ltd (ASX: COH)

COH Technical Analysis 5
As on 21st Apr 2017 COH Share Price closed @ 138.90 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 128.93 & Strong Buy for SHORT-TERM with Stoploss of 133.06 we also expect STOCK to react on Following IMPORTANT LEVELS.
COH Target for April
1st Target up-side 141.28
2nd Target up-side 145.52
3rd Target up-side 149.76
1st Target down-side 129.18
2nd Target down-side 124.94
3rd Target down-side 120.7
COH Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Appliances & Equipment
Offical website http://www.cochlear.com
COH Address
COH
1 University Avenue
Macquarie University, NSW 2109
Australia
Phone: 61 2 9428 6555
Fax: 61 2 9428 6352
COH Latest News
Interactive Technical Analysis Chart Cochlear Ltd ( COH ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Cochlear Ltd
COH Business Profile
Cochlear Limited provides implantable hearing solutions. It offers the Cochlear Nucleus range of cochlear implant systems; Baha bone conduction implants for treating conductive hearing loss, mixed hearing loss, and single-sided deafness; bone anchored prosthetics, such as the Cochlear Vistafix bone-anchored facial prosthetic solution to enhance the attachment and cosmetic outcome of facial prostheses; and support services. The company provides its products directly, as well as through distributors and agents in the United States, Canada, and Latin America; Europe, the Middle East, and Africa; and Australasia and Asia. Cochlear Limited is headquartered in Macquarie University, Australia.